Structuring Freedom-to-Operate Opinions: Reducing Risk of Patent Infringement
Combating Troubling FTO Results, Overcoming Potential Roadblocks, Addressing Impact of Post-Grant Process on FTO Opinions
Recording of a 90-minute CLE webcast with Q&A
This CLE webinar will provide guidance to patent counsel preparing and providing freedom to operate (FTO) opinions for companies developing new products. The panel will outline best practices for drafting FTO opinions to reduce infringement risks.
- Drafting FTO opinions
- Problem results
- Privilege and confidentiality
- Alternative resolutions
- Impact of the post-grant process on FTO opinions
- Strategies for employing FTO opinions
The panel will review these and other key issues:
- What are best practices for patent counsel when analyzing FTO issues and structuring FTO opinions?
- What is the impact of the post-grant process on FTO opinions?
- When should counsel seek FTO opinions to protect new research and products from infringement claims?
Doris Johnson Hines
Finnegan Henderson Farabow Garrett & Dunner
Ms. Hines focuses her practice on patent litigation and has led teams in U.S. district courts, the U.S. International... | Read More
Ms. Hines focuses her practice on patent litigation and has led teams in U.S. district courts, the U.S. International Trade Commission, and before arbitration panels. She has argued a number of cases before the U.S. Court of Appeals for the Federal Circuit. She regularly represents clients in mediations and assists in licensing negotiations. She advises clients on strategic patent prosecution, monetization strategies for issued patents, and patent damages, including issues relating to standard essential patents and fair, reasonable, and non-discriminatory (FRAND) terms.Close
Laura A. Labeots, Ph.D., J.D.
Ms. Labeots’ legal practice focuses on patent procurement (drafting and prosecution); litigation; patentability,... | Read More
Ms. Labeots’ legal practice focuses on patent procurement (drafting and prosecution); litigation; patentability, invalidity and infringement analyses; freedom-to-operate opinions; licensing agreements; appeals; and inter partes proceedings before the USPTO. Her practice is centered on the chemical arts, which stems from a combination of her masters and doctorate degrees in organic chemistry, and a decade of work as a research scientist at the bench.Close
Scott Larsen, Ph.D.
Vice President, Intellectual Property
Dr. Larsen has more than two decades of experience practicing IP law in the pharmaceutical industry. He manages all... | Read More
Dr. Larsen has more than two decades of experience practicing IP law in the pharmaceutical industry. He manages all intellectual property matters at Incyte and is currently responsible for developing and executing a comprehensive global IP strategy including supervising patent and trademark prosecution, strategy and defense for Incyte’s commercial products and pipeline; conducting patentability, freedom to operate and due diligence analyses; managing Oppositions, PGR/IPR practice, and ANDA litigation; overseeing IP aspects of Incyte’s contracts and agreements; and counseling business development and licensing activities. Prior to joining Incyte, he was Patent Counsel at Wyeth; Group Director, IP at Cephalon Inc.; and Patent Counsel at BMS/DuPont Pharmaceuticals Company.Close